Subject-by-formulation interaction in bioequivalence: conceptual and statistical issues. FDA Population/Individual Bioequivalence Working Group. Food and Drug Administration.

Hauck, W W; Hyslop, T; Chen, M L; Patnaik, R; Williams, R L

Hauck, W W; Hyslop, T; Chen, M L; Patnaik, R; Williams, R L.

Affiliation

Hauck WW; Division of Clinical Pharmacology, Thomas Jefferson University, Philadelphia, Pennsylvania, USA. w_hauck@lac.jci.tju.edu

Pharm Res ; 17(4): 375-80, 2000 Apr.

Article in En | MEDLINE | ID: mdl-10870978

Subject(s)

Therapeutic Equivalency; Chemistry, Pharmaceutical; United States; United States Food and Drug Administration

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Therapeutic Equivalency Country/Region as subject: America do norte Language: En Journal: Pharm Res Year: 2000 Document type: Article

Search on Google

XML

PubMed Links